Elanco Animal Health Company Profile

08:50 EST 19th December 2018 | BioPortfolio

Elanco is a global research-based company that develops and markets products to improve the health and production of animals in more than 100 countries. Elanco is a division of Eli Lilly and Company, a leading innovation-driven pharmaceutical corporation. Elanco products enhance animal health, wellness, welfare and performance to help the food industry produce an abundant supply of safe and affordable food.

The picture above shows Elanco’s worldwide headquarters, which is located in Greenfield, Indiana, USA. These buildings have been the home of Elanco’s research and development teams since 1954, and now also include our global sales and marketing teams. The buildings were constructed in the early 1900’s by Eli Lilly and Company for horses which were used for antitoxin production, and are now converted to offices.


2001 West Main StreetP.O. Box 708
United States of America


Phone: 800-428-4441 and 317-277-3185
Fax: 317-276-9434

News Articles [819 Associated News Articles listed on BioPortfolio]

Elanco IPO Raises $1.5B as the Animal Health Biz Spins Off from Lilly

Elanco is now a standalone company after raising $1.5 billion in its stock market debut. Greenfield, IN-based Elanco (NYSE: ELAN) sold 62.9 million shares at $24 apiece, which topped the $20 to $23 ra...

Lilly's Elanco Animal Health Prices IPO Of 62.9 Mln Shares At $24.00/shr

INDIANAPOLIS (dpa-AFX) - Elanco Animal Health Inc., a subsidiary of Eli Lilly and Company (LLY), said that it priced its initial public offering of 62.9 million shares of its common stock at a pri...

Elanco Animal Health Confirms Date and Conference Call for 2019 Financial Guidance

Elanco Animal Health Incorporated (NYSE: ELAN) will announce its financial guidance for 2019 on Tuesday, Dec. 18, 2018. Elanco will also conduct a conference call that day with th...

Elanco’s IPO Would Free Eli Lilly to Focus on Pharmaceuticals

Elanco, the animal health business of Eli Lilly, has filed for an IPO, setting in motion the process of splitting from its parent company of more than 60 years. Greenfield, IN-based Elanco set a preli...

Finance Watch: Lilly Completes Elanco Animal Health Spin-Out As New IPO Filings Keep Rising

Public Company Edition: Eli Lilly & Co. wasted no time spinning out its animal health business Elanco, which raised $1.5bn...   

Eli Lilly Plans IPO for Elanco

Eli Lilly has announced plans to spin off its Elanco animal health business, ending months of uncertainty. The US drugmaker said it will file a registration in the coming weeks with the US Securities ...

Lilly plans Elanco IPO, posts quarterly profit above estimates

Eli Lilly and Co said on Tuesday it would take its Elanco animal health business public and posted a better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalo...

Elanco Animal Health Files For U.S. IPO

PubMed Articles [4324 Associated PubMed Articles listed on BioPortfolio]

Delivery and evaluation of participatory education for animal keepers led by veterinarians and para-veterinarians around the Kanha Tiger Reserve, Madhya Pradesh, India.

We aim to investigate local perceptions of animal health challenges; current animal health knowledge; and methods to provide effective, relevant education to animal keepers in the Kanha Tiger Reserve ...

A Determinants of Health Conceptual Model for Fish and Wildlife Health.

Our objectives were to establish if the determinant of health model used in the fields of human population and public health could be adapted to wildlife health; if it was applicable to more than one ...

Brucellosis is a public health problem in southern Italy: Burden and epidemiological trend of human and animal disease.

Brucellosis is the most common global bacterial zoonotic disease. Italian annual 2015 report on animal brucellosis control that was submitted to the Integrated National Plan of the Italian Health Mini...

Exploring the Social Determinants of Animal Health.

An understanding of the One Health and EcoHealth concepts by students is dependent on medical pedagogy and veterinary medical pedagogy having similarities that allow a common discourse. Medical pedago...

Climate change and One Health.

The journal The Lancet recently published a countdown on health and climate change. Attention was focused solely on humans. However, animals, including wildlife, livestock and pets, may also be impact...

Clinical Trials [3901 Associated Clinical Trials listed on BioPortfolio]

Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers

We investigated the prevalence of animal allergy and sensitization to animal allergen among participants in international symposium of Korean association for laboratory science (laboratory...

Mycoprotein, Resistance Training, and Hypertrophy

Protein is vital for the preservation of health and optimal adaptation to training. However, animal proteins come with economic and environmental issues. The study will investigate the eff...

Animal Allergy in Korean Veterinary Researcher

The investigators will evaluate sensitization to animal allergens and allergic symptom during contacting animal allergens in Korean veterinary researchers who attend their annual conferenc...

Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents

This study will evaluate the effects of animal-assisted interactions (AAI) on stress, anxiety, and quality of life in children with a life-threatening condition and their parents. It is an...

Effect of Plant and Animal Proteins on Biomarkers of Colorectal Cancer and Type 2 Diabetes in Healthy Adults (ScenoProt)

The aim of this study is to investigate the effects of dietary plant and animal proteins on gut metabolism and markers for colorectal cancer as well as blood protein metabolites and marker...

Companies [2348 Associated Companies listed on BioPortfolio]


Elanco is a global innovation-driven company that develops and markets products to improve animal health and food animal production in more than 100 countries. Elanco employs more than 2,000 peopl...

Elanco Animal Health Incorporated

Founded in 1954, Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 90 countries around the world. We v...

Elanco Animal Health

Elanco is a global research-based company that develops and markets products to improve the health and production of animals in more than 100 countries. Elanco is a division of Eli Lilly and Company, ...

Elanco Companion Animal Health

MSD Animal Health

For 125 years, MSD has been a global health care leader working to help the world be well. MSD Animal Health, known as Merck Animal Health in the United States and Canada, is the ...

More Information about "Elanco Animal Health" on BioPortfolio

We have published hundreds of Elanco Animal Health news stories on BioPortfolio along with dozens of Elanco Animal Health Clinical Trials and PubMed Articles about Elanco Animal Health for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elanco Animal Health Companies in our database. You can also find out about relevant Elanco Animal Health Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record